[go: up one dir, main page]

MX2016000964A - Composiciones farmaceuticas para la administracion intraocular que comprenden un agente antibacteriano y un agente antiinflamatorio. - Google Patents

Composiciones farmaceuticas para la administracion intraocular que comprenden un agente antibacteriano y un agente antiinflamatorio.

Info

Publication number
MX2016000964A
MX2016000964A MX2016000964A MX2016000964A MX2016000964A MX 2016000964 A MX2016000964 A MX 2016000964A MX 2016000964 A MX2016000964 A MX 2016000964A MX 2016000964 A MX2016000964 A MX 2016000964A MX 2016000964 A MX2016000964 A MX 2016000964A
Authority
MX
Mexico
Prior art keywords
agent
pharmaceutical compositions
intraocular administration
antiinflammatory
antibacterial agent
Prior art date
Application number
MX2016000964A
Other languages
English (en)
Other versions
MX383077B (es
Inventor
T Liegner Jeffery
Scott KAROLCHYK John
Covalesky Bernard
Dilzer Richard
Peters Kallan
Original Assignee
Imprimis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50640013&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2016000964(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Imprimis Pharmaceuticals Inc filed Critical Imprimis Pharmaceuticals Inc
Publication of MX2016000964A publication Critical patent/MX2016000964A/es
Publication of MX383077B publication Critical patent/MX383077B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se describen composiciones farmacéuticas para inyección intraocular, las composiciones consisten esencialmente de una cantidad terapéuticamente efectiva de un agente anti-bacteriano (tal como moxifloxacina), una cantidad terapéuticamente efectiva de un agente anti-inflamatorio (tal como triamcinolona), al menos un excipiente farmacéuticamente aceptable y un portador farmacéuticamente aceptable. También se describen métodos para fabricar las composiciones y usarlas para inyecciones intraoculares.
MX2016000964A 2013-07-22 2014-03-27 Composiciones farmaceuticas para la administracion intraocular que comprenden un agente antibacteriano y un agente antiinflamatorio. MX383077B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361958170P 2013-07-22 2013-07-22
PCT/US2014/032026 WO2015012899A1 (en) 2013-07-22 2014-03-27 Pharmaceutical compositions for intraocular administration comprising an antibacterial agent and an antiinflammatory agent

Publications (2)

Publication Number Publication Date
MX2016000964A true MX2016000964A (es) 2016-08-03
MX383077B MX383077B (es) 2025-03-13

Family

ID=50640013

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016000964A MX383077B (es) 2013-07-22 2014-03-27 Composiciones farmaceuticas para la administracion intraocular que comprenden un agente antibacteriano y un agente antiinflamatorio.

Country Status (11)

Country Link
US (1) US20150024996A1 (es)
EP (1) EP3024475B8 (es)
JP (5) JP2016525544A (es)
KR (1) KR20160033213A (es)
AU (1) AU2014293665B2 (es)
BR (1) BR112016001544A8 (es)
CA (1) CA2919081C (es)
HK (1) HK1223824A1 (es)
IL (1) IL243750A0 (es)
MX (1) MX383077B (es)
WO (1) WO2015012899A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160279055A1 (en) 2013-07-22 2016-09-29 Imprimis Pharmaceuticals, Inc. Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof
US20150164882A1 (en) 2013-07-22 2015-06-18 Imprimis Pharmaceuticals, Inc. Pharmaceutical compositions for intraocular administration and methods for fabricating thereof
JP6682898B2 (ja) * 2016-02-17 2020-04-15 富士通株式会社 基地局、無線通信システムおよび基地局の処理方法
AU2017260327B2 (en) * 2016-05-06 2018-12-20 Harrow Ip, Llc Pharmaceutical Ophthalmic compositions and methods for fabricating thereof
JP7101694B2 (ja) 2016-11-16 2022-07-15 ペルシカ ファーマシューティカルズ リミテッド 腰痛のための抗生物質製剤
US11071724B2 (en) 2019-05-17 2021-07-27 Ocular Science, Inc. Compositions and methods for treating presbyopia
US11523987B2 (en) 2020-08-26 2022-12-13 Somerset Therapeutics, Llc Trimcinolone and moxifloxacin methods
US11484538B2 (en) 2020-08-26 2022-11-01 Somerset Therapeutics, Llc Bromfenac, prednisolone, and moxifloxacin compositions and methods
US12016855B2 (en) 2020-08-26 2024-06-25 Somerset Therapeutics, Llc Prednisolone and moxifloxacin compositions and methods
US12102632B2 (en) 2020-08-26 2024-10-01 Somerset Therapeutics, Llc Quinolone dispersions
EP4260844A1 (en) 2022-04-11 2023-10-18 Liegner, Jeffery T. Ophthalmological compositions comprising poloxamer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1192368A (ja) * 1997-07-23 1999-04-06 Ono Pharmaceut Co Ltd ベンゾピラン誘導体を主成分とする水性液剤
US6378526B1 (en) * 1998-08-03 2002-04-30 Insite Vision, Incorporated Methods of ophthalmic administration
JP2003176228A (ja) * 2001-12-11 2003-06-24 Rohto Pharmaceut Co Ltd 液 剤
US20070049552A1 (en) * 2003-04-14 2007-03-01 Babu Manoj M Fluoroquinolone formulations and methods of making and using the same
WO2006121963A2 (en) * 2005-05-10 2006-11-16 Alcon, Inc. Suspension formulations comprising an active principle, a poloxamer or meroxapol surfactant and a glycol, its use for the manufacture of a medicament for treating ophthalmic disorders
US20080262415A1 (en) * 2005-07-18 2008-10-23 Peyman Gholam A Enhanced wound healing
EP2962682B1 (en) * 2008-12-11 2018-03-28 Massachusetts Institute Of Technology Method of making a contact lens drug delivery device
US20120277199A1 (en) * 2009-10-21 2012-11-01 Otonomy, Inc. Modulation of Gel Temperature of Poloxamer-Containing Formulations
JP2013508381A (ja) * 2009-10-21 2013-03-07 オトノミ―，インク． ポロクサマーを包含する製剤のゲル化温度の調節
US20140127269A1 (en) * 2012-02-13 2014-05-08 The Schepens Eye Research Institute, Inc. Anti-Inflammatory Peptide Derived From Thrombospondin-1 and Uses Thereof

Also Published As

Publication number Publication date
US20150024996A1 (en) 2015-01-22
JP7232128B2 (ja) 2023-03-02
CA2919081C (en) 2021-11-16
BR112016001544A2 (pt) 2017-07-25
JP2021121608A (ja) 2021-08-26
JP2024001149A (ja) 2024-01-09
NZ716208A (en) 2020-12-18
KR20160033213A (ko) 2016-03-25
JP2022185059A (ja) 2022-12-13
EP3024475B8 (en) 2020-11-18
BR112016001544A8 (pt) 2021-08-03
WO2015012899A1 (en) 2015-01-29
IL243750A0 (en) 2016-04-21
CA2919081A1 (en) 2015-01-29
AU2014293665A1 (en) 2016-02-11
JP2019167376A (ja) 2019-10-03
JP2016525544A (ja) 2016-08-25
AU2014293665B2 (en) 2017-06-01
HK1223824A1 (zh) 2017-08-11
EP3024475A1 (en) 2016-06-01
JP7362870B2 (ja) 2023-10-17
MX383077B (es) 2025-03-13
EP3024475B1 (en) 2020-09-30

Similar Documents

Publication Publication Date Title
MX2016000964A (es) Composiciones farmaceuticas para la administracion intraocular que comprenden un agente antibacteriano y un agente antiinflamatorio.
MX2019005379A (es) Derivado de pirazolo-heteroarilo, metodo de preparacion y uso medico del mismo.
MX385876B (es) Composicion farmaceutica que comprende lenalidomida amorfa y un antioxidante.
BR112015018087A8 (pt) composto, composição farmacêutica e uso
CR20160200A (es) Combinaciones de inhibidores de histona desacetilasa y fármacos inmunomoduladores
MX377796B (es) Compuestos y composiciones para inducir condrogenesis.
CL2015002835A1 (es) Nuevos derivados de piridina
IN2013MU00711A (es)
IN2013MU03583A (es)
CR20150637A (es) Tratamiento de enfermedades miopaticas y neurodegenerativas por agregación de proteina mediante administración parenteral
MX2016004257A (es) Composiciones oftalmicas basadas en epinefrina para la administracion intraocular y metodos para su frabricacion.
NI201700078A (es) Pirazolpiridinaminas
DOP2016000007A (es) Pirazolpiridinas sustituidas
MX2016015211A (es) Formulaciones topicas y usos de las mismas.
DOP2017000307A (es) Formulación sólida oral que contiene irinotecán y método de preparación de la misma.
CR20160290A (es) Inhibidores tetracíclicos de autotaxina
MX2018004304A (es) DERIVADOS DE QUINOXALINA Y PIRIDOPRAZINA COMO INHIBIDORES DE PI3Kß.
CL2015002466A1 (es) Formulaciones de compuestos orgánicos
PH12017502149A1 (en) Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine ester
CO2021008962A2 (es) Derivados activos de éster de testosterona, composiciones y usos de los mismos
IN2013MU01985A (es)
MX2016011025A (es) Composiciones de grapiprant y metodos para usar las mismas.
MX381148B (es) Polipéptidos de acción prolongada y métodos para su producción y administración.
AR093252A1 (es) Composicion farmaceutica oral utilizada como antiparasitaria y antidiarreica y procesos para prepararla
AR094224A1 (es) Composicion farmaceutica en forma de una suspension oral